The New Era of Medical Due Diligence in Professional Sports
In the high-stakes world of NFL front offices, the margin between a franchise-altering acquisition and a catastrophic loss of assets is often found in a medical report. The recent saga involving the Baltimore Ravens and edge rusher Maxx Crosby highlights a growing trend: the shift toward hyper-rigorous, multi-expert medical scrutiny before finalizing blockbuster deals.
When the Ravens nearly traded their 2026 and 2027 first-round picks for Crosby, the deal didn’t collapse because of a disagreement on value, but because of a physical exam. Crosby had undergone surgery in January to repair a torn meniscus in his left knee, and the subsequent evaluation process became a masterclass in risk management.
Rather than relying solely on internal staff, Ravens GM Eric DeCosta sought a broader consensus, reviewing assessments from three different doctors, including specialists from the Dallas Cowboys and New York Giants. This trend of “cross-referencing” medical opinions suggests that GMs are increasingly unwilling to gamble high-value draft capital on a “hope for the best” recovery timeline.
The Psychology of the “Bogeyman” GM
There is a delicate balance between protecting a team’s future and maintaining a reputation as a reliable trade partner. When DeCosta and owner Steve Bisciotti decided to renege on the Crosby agreement, they knew they were walking into a “firestorm.”
In the NFL, reputation is currency. The fear that other GMs would be reluctant to do business with the Ravens became a primary narrative following the collapse of the trade. However, the “bogeyman” label is often temporary. As DeCosta noted, the “storm has subsided,” and the league quickly returns to a state of pragmatic business.
The reality is that other executives generally respect a GM who prioritizes the health of their roster over the optics of a deal. The Ravens proved this by remaining “open for business,” later executing a trade with the San Francisco 49ers—sending a fifth-round pick and a 2027 sixth-rounder to move up 21 spots for Hibner.
Risk Management: The Cost of High-Asset Trades
The Crosby situation underscores the immense pressure associated with trading multiple first-round picks. When the cost of a player includes future first-rounders, the risk isn’t just the player’s health—it’s the potential loss of several years of team building.
By choosing to walk away, the Ravens retained their 14th-overall pick, effectively hedging their bets. This approach reflects a broader trend in league strategy: the preference for “known” draft assets over “risky” veteran stars with significant injury histories.
Future Trends in Player Evaluations
As sports science evolves, we can expect to see several shifts in how teams handle these high-pressure scenarios:
- Third-Party Audits: More teams may employ independent medical consultants to provide an unbiased second or third opinion, similar to how the Ravens utilized doctors from the Cowboys and Giants.
- Conditional Asset Swaps: To avoid the “all or nothing” nature of a failed physical, more trades may include complex conditions where draft picks are only surrendered after the player hits specific health milestones.
- Enhanced Imaging: The use of more advanced imaging tests during the physical process will likely become the standard for any trade involving first-round capital.
the Crosby saga proves that in the modern NFL, the medical staff is just as influential in roster construction as the scouting department. For a GM to be “back in his happy place,” he must first ensure that the risks on the table are manageable.
Frequently Asked Questions
What happens if a player fails a physical during a trade?
The acquiring team can choose to renege on the deal, meaning the trade is cancelled and the player remains with their original team. What we have is common when medical imaging reveals risks that the acquiring team is unwilling to assume.
Can an NFL team really back out of a trade agreement?
Yes, provided the trade has not become official with the league office. Because official trades typically cannot be processed until the start of the league year, teams have a window to withdraw based on physicals or other agreed-upon conditions.
How does a “failed physical” affect a GM’s reputation?
While it can lead to short-term criticism or a “firestorm” among peers, most GMs prioritize roster health. As long as the team continues to engage in other trades, the narrative of being “difficult to do business with” usually fades.
What do you believe? Should GMs be more lenient with veteran stars, or is the “three-doctor rule” the only way to protect a franchise’s future? Let us know your thoughts in the comments below or subscribe to our newsletter for more deep dives into NFL front-office strategy.
